Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
29.41
-0.58 (-1.93%)
At close: Feb 27, 2026, 4:00 PM EST
29.35
-0.06 (-0.20%)
After-hours: Feb 27, 2026, 7:08 PM EST
Oculis Holding AG Market Cap
Oculis Holding AG has a market cap or net worth of $1.70 billion as of February 27, 2026. Its market cap has increased by 66.64% in one year.
Market Cap
1.70B
Enterprise Value
1.52B
1-Year Change
66.64%
Ranking
Category
Stock Price
$29.41
Market Cap Chart
Since May 18, 2021, Oculis Holding AG's market cap has increased from $159.07M to $1.70B, an increase of 968.80%. That is a compound annual growth rate of 64.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.70B | 47.27% |
| Dec 31, 2025 | 1.15B | 61.89% |
| Dec 31, 2024 | 713.06M | 73.50% |
| Dec 29, 2023 | 411.00M | 148.15% |
| Dec 30, 2022 | 165.63M | 4.23% |
| Dec 28, 2021 | 158.90M | -0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharvaris | 1.79B |
| RAPT Therapeutics | 1.79B |
| Agios Pharmaceuticals | 1.76B |
| Enliven Therapeutics | 1.74B |
| Definium Therapeutics | 1.74B |
| Kodiak Sciences | 1.71B |
| Oruka Therapeutics | 1.71B |
| Tango Therapeutics | 1.70B |